Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Wu Ke

Showing results (81-90 of 105) with videos related to

Pageof 11
Sort By:
International Immunopharmacology|July 26, 2023
Autophagy suppression facilitates macrophage M2 polarization via increased instability of NF-κB pathway in hepatocellular carcinomaZheng Gao, Xiao-Gang Li, Shan-Ru Feng, et al.
Journal of Cancer Research and Clinical Oncology|May 13, 2008
Identification of side population cells in human hepatocellular carcinoma cell lines with stepwise metastatic potentialsGuo-Ming Shi, Yang Xu, Jia Fan, et al.
Journal of Hepatology|March 20, 2018
Spatial and temporal clonal evolution of intrahepatic cholangiocarcinomaLiang-Qing Dong, Yang Shi, Li-Jie Ma, et al.
Cell Death & Disease|February 2, 2023
Loss of 5-hydroxymethylcytosine induces chemotherapy resistance in hepatocellular carcinoma via the 5-hmC/PCAF/AKT axisXiao-Jun Guo, Xiao-Yong Huang, Xuan Yang, et al.
Cell Death & Disease|December 14, 2017
Upregulation of B7-H4 promotes tumor progression of intrahepatic cholangiocarcinomaNan Xie, Jia-Bin Cai, Lu Zhang, et al.
Hepatology (Baltimore, Md.)|February 17, 2025
Erratum: CCL15 recruits suppressive monocytes to facilitate immune escape and disease progression in hepatocellular carcinomaLong-Zi Liu, Zhao Zhang, Bo-Hao Zheng, et al.
Hepatology (Baltimore, Md.)|August 3, 2018
CCL15 Recruits Suppressive Monocytes to Facilitate Immune Escape and Disease Progression in Hepatocellular CarcinomaLong-Zi Liu, Zhao Zhang, Bo-Hao Zheng, et al.
Journal of Hepatology|December 23, 2022
Corrigendum to: "PKCα/ZFP64/CSF1 axis resets the tumor microenvironment and fuels anti-PD1 resistance in hepatocellular carcinoma" [J Hepatol 77 (2022) 163-176]Chuan-Yuan Wei, Meng-Xuan Zhu, Peng-Fei Zhang, et al.
Journal of Hepatology|February 27, 2022
PKCα/ZFP64/CSF1 axis resets the tumor microenvironment and fuels anti-PD1 resistance in hepatocellular carcinomaChuan-Yuan Wei, Meng-Xuan Zhu, Peng-Fei Zhang, et al.
Oncotarget|January 13, 2016
Generation and characterization of a tetraspanin CD151/integrin α6β1-binding domain competitively binding monoclonal antibody for inhibition of tumor progression in HCCAi-Wu Ke, Peng-Fei Zhang, Ying-Hao Shen, et al.
Pageof 11

Showing results (81-90 of 105) with videos related to

Sort By:
Pageof 11
International Immunopharmacology|July 26, 2023
Autophagy suppression facilitates macrophage M2 polarization via increased instability of NF-κB pathway in hepatocellular carcinomaZheng Gao, Xiao-Gang Li, Shan-Ru Feng, et al.
Journal of Cancer Research and Clinical Oncology|May 13, 2008
Identification of side population cells in human hepatocellular carcinoma cell lines with stepwise metastatic potentialsGuo-Ming Shi, Yang Xu, Jia Fan, et al.
Journal of Hepatology|March 20, 2018
Spatial and temporal clonal evolution of intrahepatic cholangiocarcinomaLiang-Qing Dong, Yang Shi, Li-Jie Ma, et al.
Cell Death & Disease|February 2, 2023
Loss of 5-hydroxymethylcytosine induces chemotherapy resistance in hepatocellular carcinoma via the 5-hmC/PCAF/AKT axisXiao-Jun Guo, Xiao-Yong Huang, Xuan Yang, et al.
Cell Death & Disease|December 14, 2017
Upregulation of B7-H4 promotes tumor progression of intrahepatic cholangiocarcinomaNan Xie, Jia-Bin Cai, Lu Zhang, et al.
Hepatology (Baltimore, Md.)|February 17, 2025
Erratum: CCL15 recruits suppressive monocytes to facilitate immune escape and disease progression in hepatocellular carcinomaLong-Zi Liu, Zhao Zhang, Bo-Hao Zheng, et al.
Hepatology (Baltimore, Md.)|August 3, 2018
CCL15 Recruits Suppressive Monocytes to Facilitate Immune Escape and Disease Progression in Hepatocellular CarcinomaLong-Zi Liu, Zhao Zhang, Bo-Hao Zheng, et al.
Journal of Hepatology|December 23, 2022
Corrigendum to: "PKCα/ZFP64/CSF1 axis resets the tumor microenvironment and fuels anti-PD1 resistance in hepatocellular carcinoma" [J Hepatol 77 (2022) 163-176]Chuan-Yuan Wei, Meng-Xuan Zhu, Peng-Fei Zhang, et al.
Journal of Hepatology|February 27, 2022
PKCα/ZFP64/CSF1 axis resets the tumor microenvironment and fuels anti-PD1 resistance in hepatocellular carcinomaChuan-Yuan Wei, Meng-Xuan Zhu, Peng-Fei Zhang, et al.
Oncotarget|January 13, 2016
Generation and characterization of a tetraspanin CD151/integrin α6β1-binding domain competitively binding monoclonal antibody for inhibition of tumor progression in HCCAi-Wu Ke, Peng-Fei Zhang, Ying-Hao Shen, et al.
Pageof 11